The strategy of targeting Nrf2 could enhance the expression of Nrf2 in the cardiac to elevate the expression of HO-1 in the myocardial and then diminish cardiac hypertrophy and cardiac dysfunction [46]. This evidence concerns the gene NFE2L2 and cardiac hypertrophy.